Glucocorticoid-resistant asthma: T-lymphocyte defects

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 2 SUPPL., 1996, Pages

  Corrigan, Chris J ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; INTERLEUKIN 2; INTERLEUKIN 4; PREDNISOLONE;

AIRWAY OBSTRUCTION; ASTHMA; CELLULAR IMMUNITY; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LIGAND BINDING; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; T LYMPHOCYTE ACTIVATION;

EID: 0029738083     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm/154.2_pt_2.s53     Document Type: Review

References (20)

1. Schwartz, H. L., F. C. Lowell, and J. C. Melby. 1968. Steroid resistance in bronchial asthma. Ann. Intern. Med. 69:493-499.
2. Turner-Warwick, M. 1977. On observing patterns of airflow obstruction in chronic asthma. Br. J. Dis. Chest 71:73-86.
3. Carmichael, J. I., C. Paterson, P. Diaz, G. K. Crompton, A. B. Kay, and I. W. B. Grant. 1981. Corticosteroid resistance in chronic asthma. B.M.J. 282:1419-1422.
4. Kamada, A. K., D. Y. Leung, and S. J. Szefler. 1992. Steroid resistance in asthma: our current understanding. Pediatr. Pulmonol. 14: 180-186.
5. Kamada, A. K., D. Y. Leung, M. C. Gleason, M. R. Hill, and S. J. Szefler. 1992. High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of response. J. Allergy Clin. Immunol. 90:685-687.
6. Kamada, A. K., D. M. Leung, M. C. Gleason, M. R. Hill, and S. J. Szefler. 1992. High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of response. J. Allergy Clin. Immunol. 90:685-687.
7. Poznansky, M. C., A. C. H. Gordon, J. G. Douglas, A. S. Krajewski, A. H. Wyllie, and I. W. B. Grant. 1984. Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients. Clin. Sci. 67:639-645.
8. Corrigan, C. J., P. H. Brown, N. C. Barnes, S. J. Szefler, J. J. Tsai, A. J. Frew, and A. B. Kay. 1991. Glucocorticoid resistance in chronic asthma: glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics and inhibition of peripheral blood T-cell proliferation by glucocorticoids in vitro. Am. Rev. Respir. Dis. 144:1016-1025.
9. Corrigan, C. J., P. H. Brown, N. C. Barnes, J. J. Tsai, and A. B. Kay. 1991. Glucocorticoid resistance in chronic asthma: peripheral blood T-lymphocyte activation and a comparison of the T-lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am. Rev. Respir. Dis. 144:1026-1032.
10. Kamada, A. K., J. D. Spahn, W. Surs, E. Brown, D. Y. Leung, and S. J. Szefler. 1994. Coexistence of glucocorticoid receptor and pharmacokinetic abnormalities: factors that contribute to a poor response to treatment with glucocorticoids in children with asthma. J. Pediatr. 124:984-986.
11. Haczku, A., A. Alexander, P. Brown, B. Assoufi, B. Li, A. B. Kay, and C. Corrigan. 1994. The effect of dexamethasone, cyclosporine and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J. Allergy Clin. Immunol. 93:510-519.
12. Alexander, A. G., N. C. Barnes, and A. B. Kay. 1992. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet 339:324-328.
13. Alvarez, J., W. Surs, D. M. Leung, D. Ikle, E. W. Gelfand, and S. J. Szefler. 1992. Steroid-resistant asthma: immunologic and pharmacologic features. J. Allergy Clin. Immunol. 89:714-721.
14. Leung, D. Y., R. J. Martin, S. J. Szefler, E. R. Sher, S. Ying, A. B. Kay, and Q. Hamid. 1995. Dysregulation of interleukin 4, interleukin 5 and interferon gamma gene expression in steroid-resistant asthma. J. Exp. Med. 181:33-40.
15. Spahn, J. D., D. Y. Leung, W. Surs, R. J. Harbeck, S. Nimmagadda, and S. J. Szefler. 1995. Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation. Am. J. Respir. Crit. Care Med. 151:1709-1714.
16. Sher, E. R., D. M. Leung, W. Surs, J. C. Kam, G. Zieg, A. K. Kamada, and S. J. Szefler. 1994. Steroid-resistant asthma: cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J. Clin. Invest. 93:33-39.
17. Kam, J. C., S. J. Szefler, W. Surs, E. R. Sher, and D. Y. Leung. 1993. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J. Immunol. 151: 3460-3466.
18. Lane, S. J., J. P. Arm, D. Z. Staynov, and T. H. Lee. 1994. Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma. Am. J. Respir. Cell Mol. Biol. 11:42-48.
19. Adcock, I. M., S. J. Lane, C. R. Brown, M. J. Peters, T. H. Lee, and P. J. Barnes. 1995. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J. Immunol. 154:3500-3505.
20. Brown, P. H., S. Teelucksingh, S. P. Matusiewicz, A. P. Greening, G. K. Crompton, and C. R. Edwards. 1991. Cutaneous vasconstrictor response to glucocorticoids in asthma. Lancet 337:576-580.